756 related articles for article (PubMed ID: 10678211)
1. Outcomes of transrectal ultrasound scan of the prostate with sector biopsies for 323 New Zealand men with suspicion of prostate cancer.
Smart R
N Z Med J; 1999 Dec; 112(1101):465-9. PubMed ID: 10678211
[TBL] [Abstract][Full Text] [Related]
2. Transrectal ultrasound and core biopsies for the diagnosis of prostate cancer. A study of pretreatment investigation strategy for patients with suspected prostate cancer.
Norberg M
Acta Radiol Suppl; 1994; 393():1-21. PubMed ID: 8184698
[TBL] [Abstract][Full Text] [Related]
3. Role of systematic ultrasound-guided staging biopsies in predicting extraprostatic extension and seminal vesicle invasion in men with prostate cancer.
Okihara K; Kamoi K; Lane RB; Evans RB; Troncoso P; Babaian RJ
J Clin Ultrasound; 2002; 30(3):123-31. PubMed ID: 11948567
[TBL] [Abstract][Full Text] [Related]
4. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies.
Borboroglu PG; Comer SW; Riffenburgh RH; Amling CL
J Urol; 2000 Jan; 163(1):158-62. PubMed ID: 10604336
[TBL] [Abstract][Full Text] [Related]
5. The acceptability of transrectal ultrasound guided prostatic biopsy without anaesthesia.
Westenberg AM; Cossar EH; Lorimer LB; Costello JP
N Z Med J; 1999 Jun; 112(1090):231-2. PubMed ID: 10448997
[TBL] [Abstract][Full Text] [Related]
6. Does prostate HistoScanning™ play a role in detecting prostate cancer in routine clinical practice? Results from three independent studies.
Javed S; Chadwick E; Edwards AA; Beveridge S; Laing R; Bott S; Eden C; Langley S
BJU Int; 2014 Oct; 114(4):541-8. PubMed ID: 24224648
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer. Mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment.
Aus G
Scand J Urol Nephrol Suppl; 1994; 167():1-41. PubMed ID: 7542397
[TBL] [Abstract][Full Text] [Related]
8. Limitations of transperineal ultrasound-guided prostate biopsies.
Shinghal R; Terris MK
Urology; 1999 Oct; 54(4):706-8. PubMed ID: 10510932
[TBL] [Abstract][Full Text] [Related]
9. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
[TBL] [Abstract][Full Text] [Related]
10. The potential value of power Doppler ultrasound imaging compared with grey-scale ultrasound findings in the diagnosis of local recurrence after radical prostatectomy.
Tamsel S; Killi R; Apaydin E; Hekimgil M; Demirpolat G
Clin Radiol; 2006 Apr; 61(4):325-30; discussion 323-4. PubMed ID: 16546462
[TBL] [Abstract][Full Text] [Related]
11. Can Power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy?
Remzi M; Dobrovits M; Reissigl A; Ravery V; Waldert M; Wiunig C; Fong YK; Djavan B;
Eur Urol; 2004 Oct; 46(4):451-6. PubMed ID: 15363559
[TBL] [Abstract][Full Text] [Related]
12. Significance of routine transition zone biopsies in Japanese men undergoing transrectal ultrasound-guided prostate biopsies.
Miyake H; Kurahashi T; Muramaki M; Yamanak K; Hara I
Int J Urol; 2005 Nov; 12(11):964-8. PubMed ID: 16351652
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.
Stewart CS; Leibovich BC; Weaver AL; Lieber MM
J Urol; 2001 Jul; 166(1):86-91; discussion 91-2. PubMed ID: 11435830
[TBL] [Abstract][Full Text] [Related]
14. Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies.
Sheikh N; Wei C; Szewczyk-Bieda M; Campbell A; Memon S; Lang S; Nabi G
World J Urol; 2017 Feb; 35(2):213-220. PubMed ID: 27236302
[TBL] [Abstract][Full Text] [Related]
15. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
Noguchi M; Stamey TA; McNeal JE; Yemoto CM
J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
[TBL] [Abstract][Full Text] [Related]
16. Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer.
Washington SL; Bonham M; Whitson JM; Cowan JE; Carroll PR
BJU Int; 2012 Jul; 110(1):50-5. PubMed ID: 22077660
[TBL] [Abstract][Full Text] [Related]
17. Predictors of prostate cancer on repeat transrectal ultrasound-guided systematic prostate biopsy.
Park SJ; Miyake H; Hara I; Eto H
Int J Urol; 2003 Feb; 10(2):68-71. PubMed ID: 12588600
[TBL] [Abstract][Full Text] [Related]
18. A prospective study analysing the effect of pain on probe insertion, and the biopsy strategy, on the patients' perception of pain during TRUS-guided biopsy of the prostate.
Chopra S; Rowe EW; Laniado M; Patel A
N Z Med J; 2008 Dec; 121(1287):39-43. PubMed ID: 19098966
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic efficacy of transrectal ultrasound-guided biopsy of the prostatic fossa in patients with rising PSA following radical prostatectomy.
Deliveliotis C; Manousakas T; Chrisofos M; Skolarikos A; Delis A; Dimopoulos C
World J Urol; 2007 Jun; 25(3):309-13. PubMed ID: 17440730
[TBL] [Abstract][Full Text] [Related]
20. [Early diagnosis of prostatic carcinoma by random biopsies in 60 patients clinically negative but with PSA greater than 8.9 ng/ml].
Bianchi A; Bottanelli A; Baroni G; Rovellini P; Sciaraffia G; Toia G; Marcelli G
Arch Ital Urol Androl; 1997 Dec; 69(5):313-8. PubMed ID: 9477617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
